U

PPJ Healthcare Enterprises, Inc. PPJE

OTC PK
Recommendation
Dividend Power Score
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
--

Company Overview

PPJ Healthcare Enterprises, Inc. (OTC Pink: PPJE) is a U.S.-based healthcare services company focused primarily on medical billing, claims management, revenue cycle support, and related healthcare administrative services. Public disclosures and OTC market filings indicate the company has historically operated through healthcare management and medical practice support activities, targeting physician groups, hospitals, and healthcare providers seeking outsourced administrative functions. The company has also disclosed interests in healthcare technology and management consulting initiatives, although the scale and continuity of these operations have varied over time based on public filings.

The company was founded in 1995 and later became publicly traded through the OTC market. Over its operating history, PPJ Healthcare Enterprises has repositioned its business model several times in response to changes in healthcare reimbursement systems and healthcare administration trends in the United States. Publicly available disclosures indicate that the company has emphasized cost containment, claims processing efficiency, and provider reimbursement optimization as part of its market positioning. Data regarding sustained operating scale, current customer concentration, and long-term revenue stability is inconclusive based on available public sources.

Business Operations

PPJ Healthcare Enterprises has historically generated revenue through healthcare administrative support services, including medical billing, accounts receivable management, insurance claims processing, and practice management assistance. Public filings reference operations conducted through healthcare service subsidiaries and affiliated entities involved in billing and revenue-cycle-related activities. The company’s business model has generally centered on service fees tied to provider reimbursement management and healthcare administrative outsourcing.

The company’s operations appear to be concentrated primarily within the United States healthcare market, with no consistently verified evidence of material international operating divisions. Public disclosures over multiple reporting periods have referenced healthcare consulting initiatives and technology-oriented projects, but available information does not consistently confirm large-scale proprietary platforms or major international joint ventures. Data regarding active strategic partnerships, significant healthcare system contracts, or material international subsidiaries is inconclusive based on available public sources.

Strategic Position & Investments

PPJ Healthcare Enterprises has historically positioned itself within the healthcare administration and revenue cycle management sector, seeking opportunities tied to increasing complexity in U.S. healthcare reimbursement and insurance processing. Public company disclosures indicate periodic efforts to expand service offerings beyond traditional billing functions into broader healthcare management and consulting activities. The company has also referenced interest in healthcare technology-enabled services and operational efficiencies for provider organizations.

Available public information does not indicate large-scale acquisitions comparable to major publicly traded healthcare services firms. Similarly, publicly verifiable information regarding material equity investments, substantial portfolio holdings, or major controlled subsidiaries remains limited. While the company has periodically communicated growth-oriented initiatives through OTC disclosures and shareholder communications, independently verified evidence regarding execution scale, sustained investment deployment, or major institutional partnerships remains limited.

Geographic Footprint

PPJ Healthcare Enterprises is headquartered in the United States, with operations historically focused on domestic healthcare providers and medical administration clients. Public records and OTC disclosures primarily reference activities connected to U.S.-based healthcare reimbursement systems and provider support services rather than multinational operations.

There is no consistently verified evidence that the company maintains a significant operational footprint across Europe, Asia-Pacific, Latin America, or the Middle East. Available public filings and market disclosures instead suggest a comparatively limited geographic scope centered on regional or national healthcare administration services within the U.S. market. Data regarding international operational influence or foreign investment exposure is inconclusive based on available public sources.

Leadership & Governance

Public disclosures identify founder and long-serving executive involvement in the company’s operations and strategic direction. Leadership communications have generally emphasized healthcare cost management, operational efficiency for providers, and expansion of healthcare administrative services. Due to the company’s OTC market status and varying disclosure frequency, executive and governance information may not be updated as consistently as larger SEC-reporting issuers.

Key executives identified in public filings and company disclosures include:

  • Chandana Basu – Chief Executive Officer
  • Chandana Basu – Chairperson
  • Chandana Basu – Founder

Publicly available governance information beyond senior executive leadership is limited. Data regarding a broader executive management structure, independent board composition, or detailed governance committee activity is inconclusive based on available public sources.

Data compiled by narrative technology. May contain errors.

Top Tech Stocks
See All »
B
NVDA NASDAQ $222.27
B
AAPL NASDAQ $336.13
B
AVGO NASDAQ $357.61
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $106.73
A
Top Financial Stocks
See All »
B
B
JPM NYSE $349.67
B
V NYSE $368.29
Top Health Care Stocks
See All »
B
LLY NYSE $1,152.93
B
JNJ NYSE $269.99
B
ABBV NYSE $263.96
Top Real Estate Stocks
See All »
B
PLD NYSE $134.84
B
EQIX NASDAQ $1,021.34